MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids?

Journal of Endocrinology

Volumn 178, Issue 1, 2003, Pages 5-12

  Clark, Andy R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOOXYGENASE 2; DACTINOMYCIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VANADATE SODIUM; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; CUSHING SYNDROME; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESISTANCE; GENE FUNCTION; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL CYCLE PROTEINS; DRUG RESISTANCE; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYPERSENSITIVITY; IMMEDIATE-EARLY PROTEINS; MAP KINASE SIGNALING SYSTEM; MODELS, IMMUNOLOGICAL; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0041669330     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780005     Document Type: Review

References (98)

1. Adcock IM & Caramori G 2001 Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunology and Cell Biology 79 376-384.
2. Amano Y, Lee SW & Allison AC 1993 Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Molecular Pharmacology 43 176-182.
3. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL & Griswold DE 1996 Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. Journal of Pharmacology and Experimental Therapeutics 279 1453-1461.
4. Bantel H, Schmitz ML, Raible A, Gregor M & Schulze-Osthoff K 2002 Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB Journal 16 1832-1834.
5. Barnes PJ & Karin M 1997 Nuclear factor-kappa-B: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 336 1066-1071.
6. Belvisi MG, Wicks SL, Battram CH, Bottoms SE, Redford JE, Woodman P, Brown TJ, Webber SE & Foster ML 2001 Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. Journal of Immunology 166 1975-1982.
7. Berger SL 2002 Histone modifications in transcriptional regulation. Current Opinion in Genetics and Development 12 142-148.
8. Besedovsky H, del Rey A, Sorkin E & Dinarello CA 1986 Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 652-654.
9. Brook M, Sully G, Clark AR & Saklatvala J 2000 Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Letters 483 57-61.
10. Burgun C, Esteve L, Humblot N, Aunis D & Zwiller J 2000 Cyclic AMP-elevating agents induce the expression of MAP kinase phosphatase-1 in PC12 cells. FEBS Letters 484 189-193.
11. Caamano J & Hunter CA 2002 NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical Microbiology Reviews 15 414-429.
12. Caelles C, Gonzalez-Sancho JM & Munoz A 1997 Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes and Development 11 3351-3364.
13. Camps M, Nichols A & Arkinstall S 2000 Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB Journal 14 6-16.
14. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S & Cerami A 1986 Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. PNAS 83 1670-1674.
15. Cella N, Groner B & Hynes NE 1998 Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Molecular and Cellular Biology 18 1783-1792.
16. Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler HG & Firestone GL 1998 Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21 waf1/cip1 promoter in rat hepatoma cells. Journal of Biological Chemistry 273 1998-2007.
17. Chang MM, Juarez M, Hyde DM & Wu R 2001 Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. American Journal of Physiology 280 L107-L115.
18. Chen CY & Shyu AB 1995 AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences 20 465-470.
19. Chen CY, Del Gatto-Konczak F, Wu Z & Karin M 1998 Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280 1945-1949.
20. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC & Liu Y 2002 Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. Journal of Immunology 169 6408-6416.
21. Clark A 2000 Post-transcriptional regulation of pro-inflammatory gene expression. Arthritis Research 2 172-174.
22. Clark AR, Dean JL & Saklatvala J 2003 Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Letters (In Press).
23. Crofford LJ 2002 The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases. Endocrinology and Metabolism Clinics of North America 31 1-13.
24. De Bosscher K, Vanden Berghe W & Haegeman G 2000 Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. Journal of Neuroimmunology 109 16-22.
25. Dean JL, Brook M, Clark AR & Saklatvala J 1999 p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. Journal of Biological Chemistry 274 264-269.
26. Del Rey A, Besedovsky H, Sorkin E & Dinarello CA 1987 Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit. Annals of the New York Academy of Sciences 496 85-90.
27. Delany AM & Brinckerhoff CE 1992 Post-transcriptional regulation of collegenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. Journal of Cellular Biochemistry 50 400-410.
28. DeRijk R & Sternberg EM 1997 Corticosteroid resistance and disease. Annals of Medicine 29 79-82.
29. Diamond MI, Miner JN, Yoshinaga SK & Yamamoto KR 1990 Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 1266-1272.
30. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA & Bravo R 1996 Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13 925-931.
31. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS & Hulley PA 2003 Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144 412-422.
32. Fessler BJ, Paliogianni F, Hama N, Balow JE & Boumpas DT 1996 Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T cells: evidence for posttranscriptional regulation. Transplantation 62 1113-1118.
33. Franklin CC & Kraft AS 1997 Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. Journal of Biological Chemistry 272 16917-16923.
34. Gille J, Reisinger K, Westphal-Varghese B & Kaufmann R 2001 Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. Journal of Investigative Dermatology 117 1581-1587.
35. Gonzalez MV, Jimenez B, Berciano MT, Gonzalez-Sancho JM, Caelles C, Lafarga M & Munoz A 2000 Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. Journal of Cell Biology 150 1199-1208.
36. Gottlicher M, Heck S & Herrlich P 1998 Transcriptional cross-talk, the second mode of steroid hormone receptor action. Journal of Molecular Medicine 76 480-489.
37. Goujon E, Parnet P, Laye S, Combe C & Dantzer R 1996 Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Research. Molecular Brain Research. 36 53-62.
38. Green PG, Miao FJ, Janig W & Levine JD 1995 Negative feedback neuroendocrine control of the inflammatory response in rats. Journal of Neuroscience 15 4678-4686.
39. Guo YL, Kang B & Williamson JR 1998 Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. Journal of Biological Chemistry 273 10362-10366.
40. Hallsworth MP, Moir LM, Lai D & Hirst SJ 2001 Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle. American Journal of Respiratory and Critical Care Medicine 164 688-697.
41. Han J, Thompson P & Beutler B 1990 Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. Journal of Experimental Medicine 172 391-394.
42. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P & Cato AC 1994 A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO Journal 13 4087-4095.
43. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P & Cato AC 1997 I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO Journal 16 4698-4707.
44. Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, Tytgat G, Peppelenbosch M & Van Deventer S 2002 Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122 7-14.
45. Hulley PA, Gordon F & Hough FS 1998 Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases. Endocrinology 139 2423-2431.
46. Hulley PA, Conradie MM, Langeveldt CR & Hough FS 2002 Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate. Bone 31 220-229.
47. Ip YT & Davis RJ 1998 Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Current Opinion in Cell Biology 10 205-219.
48. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF & Adcock IM 2002 p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. Journal of Allergy and Clinical Immunology 109 649-657.
49. Ito K, Barnes PJ & Adcock IM 2000 Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1 beta-induced histone H4 acetylation oil lysines 8 and 12. Molecular and Cellular Biology 20 6891-6903.
50. Ito K, Jazrawi E, Cosio B, Barnes PJ & Adcock IM 2001 p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. Journal of Biological Chemistry 276 30208-30215.
51. Jafarian-Tehrani M & Sternberg EM 2000 Neuroendocrine and other factors in the regulation of inflammation. Annual models. Annals of the New York Academy of Sciences 917 819-824.
52. Karin M & Chang L 2001 AP-1-glucocorticoid receptor crosstalk taken to a higher level. Journal of Endocrinology 169 447-451.
53. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M & Cato AC 2001 Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO Journal 20 7108-7116.
54. Keyse SM 2000 Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Current Opinion in Cell Biology 12 186-192.
55. Keyse SM & Emslie EA 1992 Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359 644-647.
56. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F & Kollias G 1999 Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10 387-398.
57. Kracht M & Saklatvala J 2002 Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20 91-106.
58. Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M & Lee JC 2001 IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. Journal of Cellular Physiology 187 294-303.
59. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J & Clark AR 2000 Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Molecular and Cellular Biology 20 4265-4274.
60. Lasa M, Brook M, Saklatvala J & Clark AR 2001 Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Molecular and Cellular Biology 21 771-780.
61. Lasa M, Abraham SM, Boucheron C, Saklatvala J & Clark AR 2002 Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Molecular and Cellular Biology 22 7802-7811.
62. Loke TK, Sousa AR, Corrigan CJ & Lee TH 2002 Glucocorticoid-resistant asthma. Current Allergy and Asthma Reports 2 144-150.
63. Masferrer JL, Seibert K, Zweifel B & Needleman P 1992 Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. PNAS 89 3917-3921.
64. Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y & Okudaira H 1998 Regulation of interleukin-1 beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. Journal of Biological Chemistry 273 24832-24838.
65. Naar AM, Lemon BD & Tjian R 2001 Transcriptional coactivator complexes. Annual Review of Biochemistry 70 475-501.
66. Newton R 2000 Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 603-613.
67. Newton R, Seybold J, Kuitert LM, Bergmann M & Barnes PJ 1998 Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. Journal of Biological Chemistry 273 32312-32321.
68. Ono K & Han J 2000 The p38 signal transduction pathway: activation and function. Cell Signal 12 1-13.
69. Pages G, Berra E, Milanini J, Levy AP & Pouyssegur J 2000 Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. Journal of Biological Chemistry 275 26484-26491.
70. Rahman I 2002 Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochemical Pharmacology, 64 935-942.
71. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P & Schutz G 1998 DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 531-541.
72. Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P & Schutz G 2001 Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO Journal 20 7168-7173.
73. Reunanen N, Li SP, Ahonen M, Foschi M, Han J & Kahari VM 2002 Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. Journal of Biological Chemistry 277 32360-32368.
74. Ridley SH, Dean JL, Sarsfield SJ, Brook M, Clark AR & Saklatvala J 1998 A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Letters 439 75-80.
75. Rogatsky I, Logan SK & Garabedian MJ 1998 Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. PNAS 95 2050-2055.
76. Roth SY, Denu JM & Allis CD 2001 Histone acetyltransferases. Annual Review of Biochemistry 70 81-120.
77. Rutault K, Hazzalin CA & Mahadevan LC 2001 Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. Journal of Biological Chemistry 276 6666-6674.
78. Ruzek MC, Pearce BD, Miller AH & Biron CA 1999 Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. Journal of Immunology 162 3527-3533.
79. Saxena M, Williams S, Gilman J & Mustelin T 1998 Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP). Journal of Biological Chemistry 273 15340-15344.
80. Schmitz ML, Bacher S & Kracht M 2001 I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends in Biochemical-Sciences 26 186-190.
81. Shaw G & Kamen R 1986 A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46 659-667.
82. Sousa AR, Lane SJ, Soh C & Lee TH 1999 In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. Journal of Allergy and Clinical Immunology 104 565-574.
83. Sternberg EM 2001 Neuroendocrine regulation of autoimmune/inflammatory disease. Journal of Endocrinology 169 429-435.
84. Swantek JL, Cobb MH & Geppert TD 1997 Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17 6274-6282.
85. Takekawa M, Maeda T & Saito H 1998 Protein phosphatase 2 Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO Journal 17 4744-4752.
86. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y & Imai K 2000 p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO Journal 19 6517-6526.
87. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M & Fey MF 1992 Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79 45-51.
88. Treisman R 1996 Regulation of transcription by MAP kinase cascades. Current Opinion in Cell Biology 8 205-215.
89. Tuckermann JP, Reichardt HM, Arribas R, Richter KH, Schutz G & Angel P 1999 The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. Journal of Cell Biology 147 1365-1370.
90. Valledor AF, Xaus J, Comalada M, Soler C & Celada A 2000 Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. Journal of Immunology 164 29-37.
91. Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M & Haegeman G 1999 Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Molecular Pharmacology 56 797-806.
92. Vayssiere BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H & Resche-Rigon M 1997 Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Molecular Endocrinology 11 1245-1255.
93. Vermeulen L, De Wilde G, Damme PV, Vanden Berghe W & Haegeman G 2003 Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO Journal 22 1313-1324.
94. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S & Schreiber S 2002 p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. Journal of Immunology 168 5342-5351.
95. Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS & Manthey CL 1999 Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflammation Research 48 533-538.
96. Whitmarsh AJ & Davis RJ 1996 Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. Journal of Molecular Medicine 74 589-607.
97. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K & Holtmann H 1999 The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO Journal 18 4969-4980.
98. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL & Henson PM 2002 Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. Journal of Biological Chemistry 277 14884-14893.